About Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI), is a biopharmaceutical company that acquires, develops and commercializes a diversified portfolio of oncology and other drug candidates that meet critical health challenges for which there are few other treatment options. The Company’s pipeline includes promising early and late-stage drug candidates with unique formulations and mechanisms of action that address the needs of seriously ill patients, such as at-home chemotherapy and new treatment regimens for refractory disease.

Spectrum's passion to identify, develop and deliver better options for people suffering from cancer is behind every action they take. At Spectrum, everyone is committed to excellence and strives to make a difference every day.

The members of our team have over 200 years of relevant experience in both the development and marketing of oncology and urology drugs and the growth of profitable business ventures.

Our goal is to bring quality drugs to patients.

2009: Voted One of Best Companies to Work for - OC Register

2005: Voted One of Best Companies to Work for - OC Metro Magazine

Spectrum Pharmaceuticals actively seeks to leverage its extensive contacts in the pharmaceutical and scientific communities to identify potentially important drugs that require further clinical development.

We rapidly assess preclinical research, clinical data, and the commercialization potential of candidates and then through both in-licensing deals and co-development partnerships provide the expertise to bring the most promising products through the complex development process to market.